Project Grant S10OD040239
- Federal Grant Award Summary Yale University received a $633,482 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and install an Aurora CS cell sorting flow cytometer equipped with spectral detection capabilities. The award, dated May 15, 2026, with a completion date of May 14, 2027, supports the procurement of advanced fluorescence-based cell sorting instrumentation at Yale's New Haven,...
- Federal Grant Award Summary Yale University received a $297,269 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and implement an Olink proteogenomics instrumentation platform at the Yale Center for Genome Analysis (YCGA). The award, dated May 15, 2026, with a completion date of May 14, 2027, supports the expansion of YCGA's multiomics research capabilities by adding high-throughput, targeted...
- Federal Grant Award Summary The University of Pennsylvania received a $573,005 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a LUMICKS AVIDION Cell Avidity Analyzer. The award, effective May 15, 2026 through May 14, 2027, funds the purchase and installation of this high-throughput scientific instrumentation platform designed to quantitatively measure cell-cell interaction avidity—a...
- Federal Grant Award Summary Yale University received a $361,283 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of September 8, 2025, and a completion date of July 31, 2030. The award supports research titled "Frontiers in Measuring and Simulating Molecular Structures and Processes," conducted at Yale's New Haven, Connecticut facility. The research focuses on...
- Federal Grant Award Summary Yale University received a $2.0 million Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and install a dedicated whole-body Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging system at the Yale School of Medicine. This award, effective July 15, 2025 through July 14, 2027, supports the procurement of a time-of-flight (TOF) PET instrument integrated with...
- Federal Grant Award Summary Yale University received a $304,970 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through May 31, 2031. This award funds the development of next-generation mass spectrometry (MS)-based technologies designed to directly analyze membrane protein complexes and their lipid environments with precise molecular and nanoscale spatial resolution....
- Federal Grant Award Summary Yale University received a $1,205,462 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 10, 2025 through February 28, 2030. The award supports fundamental research investigating how biopolymers—including proteins, DNA, and RNA—alter their conformations at aqueous interfaces and how hydration structures modulate this behavior. This research...
- Federal Project Grant Award Summary Yale University received a $1.98 million Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) awarded on August 1, 2025, for the acquisition and installation of an Orbitrap Astral mass spectrometer system to support proteomics research through the Keck Mass Spectrometry & Proteomics Resource core facility. The Orbitrap Astral represents a state-of-the-art hybrid...
- Federal Grant Award Summary Yale University received a $460,740 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award funds research to develop novel quantitative experimental and computational methods for studying continuous phenotypic transitions in cellular states. The primary deliverables include the application of Proteolysis-Targeting...
- Federal Grant Award Summary Yale University received a $7.65 million Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Construction Support program (CFDA 93.352), effective September 15, 2025, with a completion date of May 31, 2030. The award funds the modernization and expansion of the Yale Positron Emission Tomography (PET) Core facility at Yale School of Medicine in New Haven, Connecticut. The project will enhance radiochemistry production...
Yale University received a $573,005 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an Avidion Cell Avidity Analyzer from Lumicks. The award, dated May 1, 2026 with completion anticipated by April 30, 2027, supports the installation and deployment of this advanced scientific instrument at Yale's New Haven, Connecticut campus. The Avidion analyzer represents a significant technological advancement over previous cell avidity measurement systems, enabling approximately 200 measurements per day compared to earlier models and accommodating two to three simultaneous users. The instrument incorporates four-color fluorescence capabilities to measure heterogeneous cell populations and correlate cell avidity with additional cellular reporters, while its automated design and user-friendly software enhance accessibility across research teams. The acquisition will support a broad user base spanning 12 different Yale departments, including five major users and 11 additional identified users, with multiple additional investigators expressing interest in utilizing the technology. The instrument addresses a critical research infrastructure need by measuring the mechanical forces regulating important physiological processes across diverse applications—from endothelial tight junctions and neuronal synapses to immune cell interactions—at significantly higher throughput than previously available low-throughput, single-cell assays. This shared core facility instrument will advance research across basic biological inquiry and clinical translational applications, enabling accelerated research progress across multiple scientific disciplines at the institution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $573.0k | 5/7/26 |